FutureWiseResearch: Global Market Research Reports, USA, UK

Overview

Lower Extremities Market Overview:

According to FutureWise analysis the market for lower extremities is expected to register a CAGR of 8.22% from 2023-2031.

The lower limb of a human is composed of the hips and extends up to the ankle. This portion of the lower limb is known as the lower extremity. The lower extremity region is responsible for basic functions, coordination, and movements, such as running, standing, kicking, jumping, and others. Arthritis, inflammation, and stiffness of joints are among the diseases that affect the lower extremities. Extremity products are used to treat, repair, replace, or heal injuries to the extremities, such as fractures and damage. External recovery braces, surgical implants, joint replacements, biologics, and external support implants are included in this category. Due to the increasing number of knee and hip arthroplasty procedures and revision procedures, braces and supporting systems will drive the overall growth of the market. Furthermore, an increase in bone-related disorders and a rise in geriatric populations boost the growth of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Lower Extremities Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Lower Extremities Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Lower Extremities Market:

DePuy Synthes
Stryker
Zimmer Biomet
Active Implants
Acumed
Arthrex
Avitus Orthopaedics
Biotech Limb and Brace
Bioventus
Bone Therapeutics
Bone Biologics
Ceramisys
ConforMIS
CONMED
CollPlant
DJO Global
Evolutis
Exactech
FH Orthopedics
Graftys
ICONACY Orthopedic Implants
Integra LifeSciences
implantcast
Isto Biologics
Lima Corporate
Medtronic
Merete Group
Össur
OsteoMed
Orthofix
Orthogem
Promedics Orthopaedic
Regenexx
RTI Surgical
Sigma Graft
Silver Bullet Therapeutics
Skye Biologics
Smith and Nephew
Stanmore Implants Worldwide
Surgical Appliance Industries
Wright Medical Group
Xtant Medical

(Note: The list of the major players will be updated with the latest market scenario and trends)

Lower Extremities Market Segmentation:

By Product

Braces and supporting systems
Orthobiologics
Accessories

By End User

Hospitals and clinics
ASCs

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Lower Extremities Market By Product, By End User and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Lower Extremities Market Variables, Trends & Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Type Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Lower Extremities Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Lower Extremities Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Type Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Type Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Lower Extremities Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Braces and supporting systems
  2. Orthobiologics
  3. Accessories
8. Lower Extremities Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
- 1. Hospitals and clinics
  2. ASCs
9. North America Lower Extremities Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2023-2031
10. Latin America Lower Extremities Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2023-2031
11. Europe Lower Extremities Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2023-2031
12. Asia Pacific Lower Extremities Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031
13. Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
  2.1. Saudi Arabia
  2.2. UAE
  2.3. South Africa
  2.4. Egypt
  3. Market Size (USD Million) Forecast for MEA 2023-2031
14. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. DePuy Synthes
  1.1. Company Overview
  1.2. Product Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Stryker
  2.1. Company Overview
  2.2. Product Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Zimmer Biomet
  3.1. Company Overview
  3.2. Product Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. Active Implants
  4.1. Company Overview
  4.2. Product Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Acumed
  5.1. Company Overview
  5.2. Product Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Arthrex
  6.1. Company Overview
  6.2. Product Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Avitus Orthopaedics
  7.1. Company Overview
  7.2. Product Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Biotech Limb and Brace
  8.1. Company Overview
  8.2. Product Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Bioventus
  9.1. Company Overview
  9.2. Product Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Bone Therapeutics
  10.1. Company Overview
  10.2. Product Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
  11. Bone Biologics
  11.1. Company Overview
  11.2. Product Portfolio
  11.3. SWOT Analysis
  11.4. Financial Overview
  11.5. Strategic Overview
  12. Ceramisys
  12.1. Company Overview
  12.2. Product Portfolio
  12.3. SWOT Analysis
  12.4. Financial Overview
  12.5. Strategic Overview
  13. ConforMIS
  13.1. Company Overview
  13.2. Product Portfolio
  13.3. SWOT Analysis
  13.4. Financial Overview
  13.5. Strategic Overview
  14. CONMED
  14.1. Company Overview
  14.2. Product Portfolio
  14.3. SWOT Analysis
  14.4. Financial Overview
  14.5. Strategic Overview
  15. CollPlant
  15.1. Company Overview
  15.2. Product Portfolio
  15.3. SWOT Analysis
  15.4. Financial Overview
  15.5. Strategic Overview
  16. DJO Global
  16.1. Company Overview
  16.2. Product Portfolio
  16.3. SWOT Analysis
  16.4. Financial Overview
  16.5. Strategic Overview
  17. Evolutis
  17.1. Company Overview
  17.2. Product Portfolio
  17.3. SWOT Analysis
  17.4. Financial Overview
  17.5. Strategic Overview
  18. Exactech
  18.1. Company Overview
  18.2. Product Portfolio
  18.3. SWOT Analysis
  18.4. Financial Overview
  18.5. Strategic Overview
  19. FH Orthopedics
  19.1. Company Overview
  19.2. Product Portfolio
  19.3. SWOT Analysis
  19.4. Financial Overview
  19.5. Strategic Overview
  20. Graftys
  20.1. Company Overview
  20.2. Product Portfolio
  20.3. SWOT Analysis
  20.4. Financial Overview
  20.5. Strategic Overview
  21. ICONACY Orthopedic Implants
  21.1. Company Overview
  21.2. Product Portfolio
  21.3. SWOT Analysis
  21.4. Financial Overview
  21.5. Strategic Overview
  22. Integra LifeSciences
  22.1. Company Overview
  22.2. Product Portfolio
  22.3. SWOT Analysis
  2.4. Financial Overview
  22.5. Strategic Overview
  23. implantcast
  23.1. Company Overview
  23.2. Product Portfolio
  23.3. SWOT Analysis
  23.4. Financial Overview
  23.5. Strategic Overview
  24. Isto Biologics
  24.1. Company Overview
  24.2. Product Portfolio
  24.3. SWOT Analysis
  24.4. Financial Overview
  24.5. Strategic Overview
  25. Lima Corporate
  25.1. Company Overview
  25.2. Product Portfolio
  25.3. SWOT Analysis
  25.4. Financial Overview
  25.5. Strategic Overview
  26. Medtronic
  26.1. Company Overview
  26.2. Product Portfolio
  26.3. SWOT Analysis
  26.4. Financial Overview
  26.5. Strategic Overview
  27. Merete Group
  27.1. Company Overview
  27.2. Product Portfolio
  27.3. SWOT Analysis
  27.4. Financial Overview
  27.5. Strategic Overview
  28. Össur
  28.1. Company Overview
  28.2. Product Portfolio
  28.3. SWOT Analysis
  28.4. Financial Overview
  28.5. Strategic Overview
  29. OsteoMed
  29.1. Company Overview
  29.2. Product Portfolio
  29.3. SWOT Analysis
  29.4. Financial Overview
  29.5. Strategic Overview
  30. Orthofix
  30.1. Company Overview
  30.2. Product Portfolio
  30.3. SWOT Analysis
  30.4. Financial Overview
  30.5. Strategic Overview
  31. Orthogem
  31.1. Company Overview
  31.2. Product Portfolio
  31.3. SWOT Analysis
  31.4. Financial Overview
  31.5. Strategic Overview
  32. Promedics Orthopaedic
  32.1. Company Overview
  32.2. Product Portfolio
  32.3. SWOT Analysis
  32.4. Financial Overview
  32.5. Strategic Overview
  33. Regenexx
  33.1. Company Overview
  33.2. Product Portfolio
  33.3. SWOT Analysis
  33.4. Financial Overview
  33.5. Strategic Overview
  34. RTI Surgical
  34.1. Company Overview
  34.2. Product Portfolio
  34.3. SWOT Analysis
  34.4. Financial Overview
  34.5. Strategic Overview
  35. Sigma Graft
  35.1. Company Overview
  35.2. Product Portfolio
  35.3. SWOT Analysis
  35.4. Financial Overview
  35.5. Strategic Overview
  36. Silver Bullet Therapeutics
  36.1. Company Overview
  36.2. Product Portfolio
  36.3. SWOT Analysis
  36.4. Financial Overview
  36.5. Strategic Overview
  37. Skye Biologics
  37.1. Company Overview
  37.2. Product Portfolio
  37.3. SWOT Analysis
  37.4. Financial Overview
  37.5. Strategic Overview
  38. Smith & Nephew
  38.1. Company Overview
  38.2. Product Portfolio
  38.3. SWOT Analysis
  38.4. Financial Overview
  38.5. Strategic Overview
  39. Stanmore Implants Worldwide
  39.1. Company Overview
  39.2. Product Portfolio
  39.3. SWOT Analysis
  39.4. Financial Overview
  39.5. Strategic Overview
  40. Surgical Appliance Industries
  40.1. Company Overview
  40.2. Product Portfolio
  40.3. SWOT Analysis
  40.4. Financial Overview
  40.5. Strategic Overview
  41. Wright Medical Group
  41.1. Company Overview
  41.2. Product Portfolio
  41.3. SWOT Analysis
  41.4. Financial Overview
  41.5. Strategic Overview
  42. Xtant Medical
  42.1. Company Overview
  42.2. Product Portfolio
  42.3. SWOT Analysis
  42.4. Financial Overview
  42.5. Strategic Overview
16. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients